Researchers identify new cause of brain defects in tuberous sclerosis patients

February 9, 2017, Rockefeller University Press
Electron microscopy shows that, compared to a mouse lacking neuronal Tsc1 (left), the number of axons wrapped in a myelin sheath is increased in the brain of a mouse that also lacks CTGF (right). Credit: Ercan et al., 2017

Boston Children's Hospital researchers have uncovered a new molecular pathway that inhibits the myelination of neurons in the brains of patients with the rare genetic disorder tuberous sclerosis complex (TSC). The study, "Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex," which will be published online February 9 in The Journal of Experimental Medicine, suggests new ways to treat some of the neurological symptoms associated with TSC, including autism and epilepsy.

TSC is caused by mutations in the genes TSC1 and TSC2. The disease affects approximately 1 in 6,000 people and is characterized by the growth of numerous benign tumors in different tissues of the body, including the brain, skin, eyes, kidneys, heart, and lungs. Many patients also have such as epilepsy, intellectual disability, and autism. Patients' brains show various abnormal structures. In particular, TSC patients with autism show defects in the organization of their , the regions of the brain where oligodendrocyte cells protect neuronal axons by wrapping them in an insulating myelin sheath.

Mustafa Sahin and colleagues previously found that mice whose lack TSC1 fail to myelinate their axons correctly, but the reason for this defect remained unclear. Sahin's team at Boston Children's Hospital and Harvard Medical School now reveal that neurons lacking TSC1 secrete increased amounts of a protein called connective tissue growth factor (CTGF) and that this protein impedes oligodendrocyte development and myelination. Deleting the gene encoding CTGF restored the ability of oligodendrocytes to myelinate axons in mice lacking neuronal TSC1.

Sahin and colleagues found that CTGF levels were also elevated in neurons derived from TSC patients. "Our study provides the first description of a molecular mechanism that could underlie the aberrant white matter microstructure in TSC ," Sahin says. "Future studies of the effects of CTGF on oligodendrocyte development will be a major goal for the discovery of new therapeutic targets."

The researchers add that the role of CTGF secreted from neurons should be investigated in other myelination diseases, including multiple sclerosis and some forms of cerebral palsy.

Explore further: Oligodendrocytes selectively myelinate a particular set of axons in the white matter

More information: The Journal of Experimental Medicine, DOI: 10.1084/jem.20160446

Related Stories

Oligodendrocytes selectively myelinate a particular set of axons in the white matter

October 21, 2016
There are three kinds of glial cells in the brain: oligodendrocytes, astrocytes and microglia. Oligodendrocytes myelinate neuronal axons to increase conduction velocity of neuronal impulses. A Japanese research team at the ...

Impaired recycling of mitochondria in autism?

October 18, 2016
Tuberous sclerosis complex (TSC), a genetic disorder that causes autism in about half of those affected, could stem from a defect in a basic system cells use to recycle their mitochondria, report scientists at Boston Children's ...

Autism may involve disordered white matter in the brain

December 5, 2011
It's still unclear what's different in the brains of people with autism spectrum disorders (ASDs), but evidence from genetic and cell studies points to abnormalities in how brain cells (neurons) connect to each other. A study ...

Deleting a single gene results in autism-like behavior; immunosuppressant drug prevents symptoms

July 2, 2012
Deleting a single gene in the cerebellum of mice can cause key autistic-like symptoms, researchers have found. They also discovered that rapamycin, a commonly used immunosuppressant drug, prevented these symptoms.

Recommended for you

Ambitious global virome project could mark end of pandemic era

February 23, 2018
Rather than wait for viruses like Ebola, SARS and Zika to become outbreaks that force the world to react, a new global initiative seeks to proactively identify, prepare for and stop viral threats before they become pandemics.

Forecasting antibiotic resistance with a 'weather map' of local data

February 23, 2018
The resistance that infectious microbes have to antibiotics makes it difficult for physicians to confidently select the right drug to treat an infection. And that resistance is dynamic: It changes from year to year and varies ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.